Synonym:
(S)-(+)-2-Ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid,
Novonorm,
Prandin
Properties:
| Related Categories |
Analytical Standards,
Analytical/Chromatography,
Pharmacopeia & Metrological Institutes Standards,
USP Standards,
USP Standards P - R
|
Description:
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia
.
Other Notes
Sales restrictions may apply.
USP issued SDS can be found here
.
Biochem/physiol Actions
Repaglinide is a potent short-acting insulin secretagogue that acts by closing ATP-sensitive potassium (KATP) channels in the plasma membrane of the pancreatic beta cell. It represents a new class of insulin secretagogues, structurally unrelated to sulphonylureas, which were developed for the treatment of type 2 diabetes.
Safety:
RIDADR
NONH for all modes of transport